Ionic Regulation of Cell Volume Changes and Cell Death after Ischemic Stroke

被引:0
作者
Mingke Song
Shan Ping Yu
机构
[1] Emory University School of Medicine,Department of Anesthesiology
来源
Translational Stroke Research | 2014年 / 5卷
关键词
Stroke; Ionic mechanism; Potassium channels; Na; /K; -ATPase; Sodium pump; Hybrid cell death; Cell volume regulation;
D O I
暂无
中图分类号
学科分类号
摘要
Stroke is a leading cause of human death and disability in the USA and around the world. Shortly after the cerebral ischemia, cell swelling is the earliest morphological change in injured neuronal, glial, and endothelial cells. Cytotoxic swelling directly results from increased Na+ (with H2O) and Ca2+ influx into cells via ionic mechanisms evoked by membrane depolarization and a number of harmful factors such as glutamate accumulation and the production of oxygen reactive species. During the sub-acute and chronic phases after ischemia, injured cells may show a phenotype of cell shrinkage due to complex processes involving membrane receptors/channels and programmed cell death signals. This review will introduce some progress in the understanding of the regulation of pathological cell volume changes and the involved receptors and channels, including NMDA and AMPA receptors, acid-sensing ion channels, hemichannels, transient receptor potential channels, and KCNQ channels. Moreover, accumulating evidence supports a key role of energy deficiency and dysfunction of Na+/K+-ATPase in ischemia-induced cell volume changes and cell death. Specifically, the Na+ pump failure is a prerequisite for disruption of ionic homeostasis including a pro-apoptotic disruption of the K+ homeostasis. Finally, we will introduce the concept of hybrid cell death as a result of the Na+ pump failure in cultured cells and the ischemic brain. The goal of this review is to outline recent understanding of the ionic mechanism of ischemic cytotoxicity and suggest innovative ideas for future translational research.
引用
收藏
页码:17 / 27
页数:10
相关论文
共 506 条
  • [1] Go AS(2013)Heart disease and stroke statistics—2013 update: a report from the American Heart Association Circulation 127 e6-e245
  • [2] Mozaffarian D(2008)Combinatorial-approached neuroprotection using pan-caspase inhibitor and poly (ADP-ribose) polymerase (PARP) inhibitor following experimental stroke in rats; is there additional benefit? Brain Res 1195 130-138
  • [3] Roger VL(2005)Soman-induced convulsions: the neuropathology revisited Toxicology 215 1-24
  • [4] Benjamin EJ(2002)Heart, and Stroke Foundation of Ontario Centre of Excellence in Stroke, R., Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions Stroke 33 2123-2136
  • [5] Berry JD(2009)Current status of neuroprotection for cerebral ischemia: synoptic overview Stroke 40 S111-S114
  • [6] Borden WB(2012)Neuroprotection for stroke: current status and future perspectives Int J Mol Sci 13 11753-11772
  • [7] Yap E(2012)Neuroprotection for ischaemic stroke: translation from the bench to the bedside Int J Stroke 7 407-418
  • [8] Tan WL(2003)New light on white matter Stroke 34 330-332
  • [9] Ng I(2006)Ischemic thresholds for gray and white matter: a diffusion and perfusion magnetic resonance study Stroke 37 1211-1216
  • [10] Ng YK(1996)Cerebral white matter is highly vulnerable to ischemia Stroke 27 1641-1646